Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01523613 · ClinicalTrials.gov registry record · NA

High-strength Glass-ionomer Dental Restorations

A NA study of Dental Caries, sponsored by Mathilde Peters, DMD, PhD.

Completed
Registry status
NA
Development phase
93
Enrollment target
1
Study location

NCT01523613: Completed NA study of Dental Caries, sponsored by Mathilde Peters, DMD, PhD.

NCT01523613 is a NA study of Dental Caries that has completed, run by Mathilde Peters, DMD, PhD. The registered enrollment target is 93 participants, below the 719-participant average among 30 other Dental Caries trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01523613, a NA study of Dental Caries, has completed, sponsored by Mathilde Peters, DMD, PhD.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to extend our knowledge concerning the clinical performance of two dental filling materials in molars. The study will compare two high-strength glass-ionomer filling materials. The investigators hypothesize that after two years (1) the clinical performance of both filling materials shows a similar survival rate, (2) the ChemFil Rock fillings show similar or higher incidence of fracture than Fuji IX GP fillings.

Primary Outcome

* Cut-off: Restoration failure as determined by (need for) replacement due to fracture and retention losses within both arms. * "Clinically successful" is defined as: no need for replacement due to fracture or retention losses.

Conditions Studied

Interventions

  • DEVICE Chemfil ROCK Glassionomer restoration
  • DEVICE Fuji IX GP Extra Glassionomer restoration

Study Locations (1)

Michigan

  • Mott Childrens' Health Center - Flint

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2011-11
Est. Completion 2014-10
Phase NA
Mathilde Peters, DMD, PhD

1 total trials

What the finished NCT01523613 record still lists

NCT01523613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 719-participant average among 30 other Dental Caries trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 2 interventions - of which Chemfil ROCK Glassionomer restoration is the first listed.

NCT01523613 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01523613 about?

NCT01523613 is a clinical study titled "High-strength Glass-ionomer Dental Restorations". The purpose of this study is to extend our knowledge concerning the clinical performance of two dental filling materials in molars. The study will compare two high-strength glass-ionomer filling materials. The investigators hypothesize that after two years (1) the clinical performance of both filli...

What is the current status of trial NCT01523613?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2011-11. Estimated completion is 2014-10.

What conditions does trial NCT01523613 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT01523613?

The interventions under investigation include: Chemfil ROCK Glassionomer restoration (DEVICE), Fuji IX GP Extra Glassionomer restoration (DEVICE).

Who is sponsoring clinical trial NCT01523613?

This trial is sponsored by Mathilde Peters, DMD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01523613 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01523613's enrollment target sits among peer trials

93 11th of 30 higher than 20 of 30 other Dental Caries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dental Caries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02203526 · 93 participants · Phase 1

    Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

  • NCT03089554 · 93 participants · Phase 2

    Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

  • NCT05000021 · 93 participants · NA

    Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

  • NCT05489887 · 93 participants · Phase 2

    Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01523613, the US trial registry maintained by the National Library of Medicine. NCT01523613 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.